OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Nagalla on the Utility of DOACs in MPN-Associated Thrombosis

January 22nd 2020

Srikanth Nagalla, MD, discusses the utility of direct oral anticoagulants in patients with a myeloproliferative neoplasm–associated venous thromboembolism.

Dr. Ribeiro on the Role of Surgery in Pancreatic Cancer

January 22nd 2020

Afonso Ribeiro, MD, discusses the role of surgery in treating patients with pancreatic cancer.

Dr. Alva on TKI Monotherapy and Combinations for RCC

January 22nd 2020

Ajjai Shivaram Alva, MBBS, discusses TKI monotherapy and in combination with immunotherapy for patients with renal cell carcinoma.

Dr. Mims on the Emergence of Targeted Therapy in AML

January 22nd 2020

Alice S. Mims, MD, discusses the emergence of targeted therapy in acute myeloid leukemia treatment.

Dr. Coleman on Implications of the VELIA Trial in Ovarian Cancer

January 21st 2020

Robert L. Coleman, MD, FACOG, FACS, professor and Ann Rife Cox Chair in Gynecology, Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, discusses the implications of the phase III VELIA trial in ovarian cancer.

Dr. Sparano on the Utility of Liquid Biopsies in Breast Cancer

January 21st 2020

Joseph A. Sparano, MD, associate director for clinical research, Albert Einstein Cancer Center, professor of Medicine & Obstetrics, Gynecology, and Women’s Health at the Albert Einstein College of Medicine, and associate chairman for Clinical Research in the Department of Oncology at Montefiore Medical Center, discusses the utility of liquid biopsies in breast cancer.

Dr. Koo on Metastasis-Directed Therapy in Prostate Cancer

January 21st 2020

Phillip J. Koo, MD, division chief of Diagnostic Imaging, Banner MD Anderson Cancer Center, discusses the use of metastasis-directed therapy in prostate cancer.

Dr. Kasi on Utility of Personalized Medicine in Colorectal Cancer

January 21st 2020

Pashtoon M. Kasi, MD, discusses the recycling of therapies in patients with colorectal cancer (CRC).

Dr. Moore on Benefit of Mirvetuximab Soravtansine in Ovarian Cancer

January 21st 2020

Kathleen Moore, MD, discusses the benefit of mirvetuximab soravtansine in patients with platinum-resistant ovarian cancer.

Dr. Choti on Future Treatment of Patients With Stage IV Pancreatic Cancer

January 21st 2020

Michael A. Choti, MD, discusses the future of treatment for patients with stage IV pancreatic cancer.

Dr. Schmid on Activity With Neoadjuvant Pembrolizumab in TNBC

January 21st 2020

Peter Schmid, MD, PhD, discusses the benefit of pembrolizumab when added to neoadjuvant chemotherapy in patients with triple-negative breast cancer.

Dr. Pagel on the ELEVATE-TN Trial in CLL

January 21st 2020

John M. Pagel, MD, PhD, discusses the phase III ELEVATE-TN trial in chronic lymphocytic leukemia.

Dr. Wang on the ZUMA-2 Trial in Relapsed/Refractory MCL

January 21st 2020

Michael Wang, MD, discusses the results of the phase II ZUMA-2 trial in relapsed/refractory mantle cell lymphoma.

Incorporating Precision Medicine into Oncology

January 21st 2020

Terrill Jordan, LLM, JD, MAcc, discusses challenges regarding the utility of precision medicine in oncology.

Dr. Dunavin on Frontline Treatment in Myelofibrosis

January 21st 2020

Neil Dunavin, MD, MS, discusses frontline treatment in myelofibrosis.

Dr. Moskowitz on Important Updates in Hodgkin Lymphoma

January 21st 2020

Alison J. Moskowitz, MD, discusses important updates in Hodgkin lymphoma.

Dr. Mohler on Need for Genetic Counselors for Early Detection of Prostate Cancer

January 20th 2020

James L. Mohler, MD, discusses the need for genetic counselors in the detection and treatment of prostate cancer.

Dr. Copeland on the Role of Chemotherapy in Ovarian Cancer

January 18th 2020

Larry J. Copeland, MD, discusses the role of chemotherapy in ovarian cancer.

Dr. Kaplan on Frontline Treatment Options in Follicular Lymphoma

January 18th 2020

Lawrence D. Kaplan, MD, discusses frontline treatment options in follicular lymphoma.

Dr. Wong on Mitigating Toxicities of Selinexor in R/R Multiple Myeloma

January 18th 2020

Sandy Wong, MD, discusses ways to mitigate the toxicities of selinexor in patients with relapsed/refractory multiple myeloma.